JP2007106777A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007106777A5 JP2007106777A5 JP2007017195A JP2007017195A JP2007106777A5 JP 2007106777 A5 JP2007106777 A5 JP 2007106777A5 JP 2007017195 A JP2007017195 A JP 2007017195A JP 2007017195 A JP2007017195 A JP 2007017195A JP 2007106777 A5 JP2007106777 A5 JP 2007106777A5
- Authority
- JP
- Japan
- Prior art keywords
- desloratadine
- mometasone furoate
- medicament
- use according
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41508399A | 1999-10-08 | 1999-10-08 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001529720A Division JP2003511417A (ja) | 1999-10-08 | 2000-10-05 | 局所的鼻疾患治療 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007295933A Division JP2008056698A (ja) | 1999-10-08 | 2007-11-14 | 局所的鼻疾患治療 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007106777A JP2007106777A (ja) | 2007-04-26 |
| JP2007106777A5 true JP2007106777A5 (enExample) | 2007-12-27 |
Family
ID=23644317
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001529720A Withdrawn JP2003511417A (ja) | 1999-10-08 | 2000-10-05 | 局所的鼻疾患治療 |
| JP2007017195A Pending JP2007106777A (ja) | 1999-10-08 | 2007-01-26 | 局所的鼻疾患治療 |
| JP2007295933A Pending JP2008056698A (ja) | 1999-10-08 | 2007-11-14 | 局所的鼻疾患治療 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001529720A Withdrawn JP2003511417A (ja) | 1999-10-08 | 2000-10-05 | 局所的鼻疾患治療 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007295933A Pending JP2008056698A (ja) | 1999-10-08 | 2007-11-14 | 局所的鼻疾患治療 |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP1227812B1 (enExample) |
| JP (3) | JP2003511417A (enExample) |
| AR (1) | AR025964A1 (enExample) |
| AT (1) | ATE359784T1 (enExample) |
| AU (1) | AU7859800A (enExample) |
| CA (1) | CA2383970A1 (enExample) |
| DE (1) | DE60034476T2 (enExample) |
| ES (1) | ES2284531T3 (enExample) |
| WO (1) | WO2001026658A2 (enExample) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003264859A1 (en) * | 2001-12-21 | 2003-12-19 | Sampad Bhattacharya | Intranasal pharmaceutical compositions comprising an antihistamine and a leukotriene inhibitor |
| TR200201343A2 (tr) * | 2002-05-17 | 2003-12-22 | Orva İlaç Sanayi̇ Ve Ti̇caret A. Ş. | Kortikosteroid ve antiseptik içeren farmasötik bileşim |
| EP1560586A1 (en) * | 2002-11-12 | 2005-08-10 | Alcon, Inc. | The use of an anti-allergy agent and a steroid to treat allergic rhinitis |
| EP1605863B1 (en) | 2003-03-14 | 2016-09-07 | Intersect ENT, Inc. | Sinus delivery of sustained release therapeutics |
| WO2004082589A2 (en) * | 2003-03-20 | 2004-09-30 | Ranbaxy Laboratories Limited | Nasally administrable, bioavailable pharmaceutical composition of loratadine |
| US20050192261A1 (en) * | 2003-09-15 | 2005-09-01 | Jost-Price Edward R. | Methods and reagents for the treatment of immunoinflammatory disorders |
| LT2522365T (lt) | 2004-11-24 | 2017-02-10 | Meda Pharmaceuticals Inc. | Kompozicijos, apimančios azelastiną, ir jų panaudojimo būdai |
| US20070020330A1 (en) | 2004-11-24 | 2007-01-25 | Medpointe Healthcare Inc. | Compositions comprising azelastine and methods of use thereof |
| US8758816B2 (en) | 2004-11-24 | 2014-06-24 | Meda Pharmaceuticals Inc. | Compositions comprising azelastine and methods of use thereof |
| US8025635B2 (en) | 2005-04-04 | 2011-09-27 | Intersect Ent, Inc. | Device and methods for treating paranasal sinus conditions |
| US20070099883A1 (en) * | 2005-10-07 | 2007-05-03 | Cheryl Lynn Calis | Anhydrous mometasone furoate formulation |
| US8637469B2 (en) | 2006-07-11 | 2014-01-28 | Roy C. Levitt | Rhinosinusitis prevention and therapy with proinflammatory cytokine inhibitors |
| DE102006034883A1 (de) * | 2006-07-25 | 2008-01-31 | Hermal Kurt Herrmann Gmbh & Co. Ohg | Pharmazeutische Zusammensetzung enthaltend Mometasonfuroat |
| EP2083798A1 (en) * | 2006-10-19 | 2009-08-05 | Cipla Limited | Pharmaceutical compositions and nasal spray incorporating anhydrous mometasone furoate |
| EP2231065B8 (en) | 2007-12-18 | 2021-01-06 | Intersect ENT, Inc. | Self-expanding devices |
| CA2732355A1 (en) | 2008-08-01 | 2010-02-04 | Intersect Ent, Inc. | Methods and devices for crimping self-expanding devices |
| KR101099826B1 (ko) | 2009-02-16 | 2011-12-27 | 서울대학교산학협력단 | 항알러지성 약물을 활성성분으로 함유하는 비강투여용 액상제제 |
| US10357640B2 (en) | 2009-05-15 | 2019-07-23 | Intersect Ent, Inc. | Expandable devices and methods for treating a nasal or sinus condition |
| WO2011141929A2 (en) | 2010-05-11 | 2011-11-17 | Cadila Healthcare Limited | Aqueous pharmaceutical compositions of fluticasone and olopatadine |
| FR2970180B1 (fr) * | 2011-01-06 | 2013-08-02 | Substipharm Dev | Procede de preparation de suspensions aqueuses pharmaceutiques comprenant un medicament efficace dans le traitement des rhinites |
| CN103828056A (zh) | 2011-09-21 | 2014-05-28 | 三菱电机株式会社 | 碳化硅半导体装置及其制造方法 |
| CN105188831B (zh) | 2013-03-14 | 2021-01-01 | 因特尔赛克特耳鼻喉公司 | 用于治疗鼻窦病状的系统、装置以及方法 |
| US9937189B2 (en) | 2013-09-13 | 2018-04-10 | Glenmark Specialty S.A. | Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine |
| PT3043773T (pt) | 2013-09-13 | 2021-10-04 | Glenmark Specialty Sa | Composição farmacêutica de dose fixa estável composta por mometasona e olopatadina para administração nasal |
| US9370483B2 (en) | 2013-09-13 | 2016-06-21 | Glenmark Specialty S.A. | Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine |
| US10653661B2 (en) | 2013-10-04 | 2020-05-19 | Glenmark Specialty S.A. | Treatment of allergic rhinitis using a combination of mometasone and olopatadine |
| RU2686670C2 (ru) | 2013-10-04 | 2019-04-30 | Гленмарк Спешиалити С.А. | Лечение аллергического ринита с использованием комбинации мометазона и олопатадина |
| US10016443B2 (en) | 2013-10-04 | 2018-07-10 | Glenmark Specialty S.A. | Treatment of allergic rhinitis using a combination of mometasone and olopatadine |
| US10548907B2 (en) | 2013-10-04 | 2020-02-04 | Glenmark Specialty S.A. | Treatment of allergic rhinitis using a combination of mometasone and olopatadine |
| US10758550B2 (en) | 2013-10-04 | 2020-09-01 | Glenmark Specialty S.A. | Treatment of allergic rhinitis using a combination of mometasone and olopatadine |
| US11679210B2 (en) | 2014-10-03 | 2023-06-20 | Glenmark Specialty S.A. | Dispensing device and pharmaceutical composition for the treatment of rhinitis |
| US20160120928A1 (en) * | 2014-11-03 | 2016-05-05 | Zent, Inc. | Nasal spray |
| EP3331498B1 (en) * | 2015-08-04 | 2020-03-11 | WindStar Medical GmbH | A nasal composition |
| CN106619504A (zh) * | 2016-11-10 | 2017-05-10 | 北京万全德众医药生物技术有限公司 | 一种地氯雷他定口服滴剂及其制备方法 |
| EA202091744A1 (ru) * | 2018-02-23 | 2021-01-15 | Гленмарк Спешиалти С.А. | Лечение аллергического ринита у субъектов детской возрастной категории с применением комбинации мометазона и олопатадина |
| US12303635B2 (en) | 2018-04-16 | 2025-05-20 | Glenmark Specialty S.A. | Dispensing device and pharmaceutical composition for the treatment of rhinitis |
| JP7337791B2 (ja) * | 2018-06-22 | 2023-09-04 | 参天製薬株式会社 | デスロラタジン又はその塩を含有する医薬組成物 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1992022288A1 (en) * | 1991-06-10 | 1992-12-23 | Schering Corporation | Non-chlorofluorocarbon aerosol formulations |
| PE44995A1 (es) * | 1994-01-27 | 1995-12-18 | Schering Corp | Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias |
| US5595997A (en) * | 1994-12-30 | 1997-01-21 | Sepracor Inc. | Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine |
| EP0780127A1 (en) * | 1995-12-19 | 1997-06-25 | The Procter & Gamble Company | A nasal spray containing a steroid and a antihistamine |
| EP0954318A1 (en) * | 1996-06-04 | 1999-11-10 | The Procter & Gamble Company | A nasal spray containing an intranasal steroid and an antihistamine |
| US5939426A (en) * | 1997-02-28 | 1999-08-17 | Sepracor Inc. | Methods for treating urinary incontinence using descarboethoxyloratadine |
| AU3065299A (en) * | 1999-03-01 | 2000-09-21 | Schering Corporation | Compositions and methods for treating atopic dermatitis, angioedema and other disorders using antihistamines and glucocorticoids |
-
2000
- 2000-10-05 AT AT00968725T patent/ATE359784T1/de not_active IP Right Cessation
- 2000-10-05 EP EP00968725A patent/EP1227812B1/en not_active Expired - Lifetime
- 2000-10-05 WO PCT/US2000/027463 patent/WO2001026658A2/en not_active Ceased
- 2000-10-05 ES ES00968725T patent/ES2284531T3/es not_active Expired - Lifetime
- 2000-10-05 CA CA002383970A patent/CA2383970A1/en not_active Abandoned
- 2000-10-05 JP JP2001529720A patent/JP2003511417A/ja not_active Withdrawn
- 2000-10-05 DE DE60034476T patent/DE60034476T2/de not_active Expired - Lifetime
- 2000-10-05 AU AU78598/00A patent/AU7859800A/en not_active Abandoned
- 2000-10-05 AR ARP000105256A patent/AR025964A1/es unknown
-
2007
- 2007-01-26 JP JP2007017195A patent/JP2007106777A/ja active Pending
- 2007-11-14 JP JP2007295933A patent/JP2008056698A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007106777A5 (enExample) | ||
| JP2010132695A5 (enExample) | ||
| JP2014530231A5 (enExample) | ||
| ME02342B (me) | Farmaceutske formulacije rastvora za izmjerene doze inhalatora pod pritiskom | |
| JP2014528470A5 (enExample) | ||
| HK1203149A1 (en) | Novel dosage form and formulation of abediterol | |
| JP2013224331A5 (enExample) | ||
| WO2009112273A3 (en) | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease | |
| JP2016040316A5 (enExample) | ||
| HRP20151214T4 (hr) | Pripravak za inhalaciju koji sadrži aklidinij za liječenje kronične opstruktivne plućne bolesti | |
| TR201000680A2 (tr) | Tiotropyum, formoterol ve budesonid içeren farmasötik bileşimler | |
| CL2013003497A1 (es) | Producto farmacéutico de combinación en forma de polvo seco para administración por medio de un inhalador que comprende una sal de umeclidinio de un grupo definido y 100 mcg/dosis de furoato de fluticasona, sin otros activos adicionales; uso para el tratamiento de enfermedades inflamatorias o del aparato respiratorio. | |
| WO2014016548A3 (en) | Pharmaceutical composition comprising olodaterol and one or more further active pharmaceutical ingredient | |
| EA201201390A1 (ru) | Кнопочное устройство мундштука ингалятора сухого порошка | |
| JP2014504636A5 (enExample) | ||
| JP2014520874A5 (enExample) | ||
| CY1117596T1 (el) | Φαρμακευτικeς συνθeσεις αερολyματος φορμοτερολης και διπροπιονικης βεκλομεθαζονης | |
| WO2011093815A3 (en) | Pharmaceutical compositions comprising formoterol and mometasone | |
| CO6270213A2 (es) | Composiciones farmaceuticas que comprenden acido montelukast y un unhibidor depde-4 o un corticoesteroide inhalado para administracion por inhalacion | |
| JP2011500731A5 (enExample) | ||
| JP2015536334A5 (enExample) | ||
| JP2013522295A5 (enExample) | ||
| HRP20221034T1 (hr) | Aklidinij za upotrebu u povećanju fizičke aktivnosti u dnevnom životu kod pacijenta koji pati od kronične opstruktivne bolesti pluća | |
| JP2016525147A5 (enExample) | ||
| EA201201394A1 (ru) | Ингалятор для доставки лекарственного средства в виде сухого порошка |